Skip to main content

What the FDA labels say about taking them together

Midodrine and phenylephrine

Midodrine's FDA label of December 4, 2025 names phenylephrine in its drug interactions section; the phenylephrine labels PlainMeds reads (4) do not name midodrine. The midodrine label: “The risk of hypertension increases with concomitant administration of drugs that increase blood pressure.”

Check it at the source: the midodrine FDA label on DailyMed (effective December 4, 2025, Novugen Pharma (USA) LLC); the phenylephrine FDA label on DailyMed (effective August 19, 2026, Hikma Pharmaceuticals USA Inc.).

What does the midodrine label say about phenylephrine?

Midodrine label, drug interactions

The risk of hypertension increases with concomitant administration of drugs that increase blood pressure (phenylephrine, pseudoephedrine, ephedrine, dihydroergotamine, thyroid hormones, or droxidopa).

Source: FDA drug label (Midodrine Hydrochloride), Novugen Pharma (USA) LLC, effective December 4, 2025 (SPL set 2bf011fe-d114-42a4-93e2-76a993a3ba34), via openFDA; the full label on DailyMed

What does the phenylephrine label say about midodrine?

Phenylephrine's label (effective August 19, 2026) and its 3 other brand-application labels do not name midodrine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenylephrine Hydrochloride), Hikma Pharmaceuticals USA Inc., effective August 19, 2026 (SPL set e1a7ab4b-0afe-4463-a039-5be0323cf2f7), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

33Midodrine generic labelers
33Phenylephrine generic labelers
MidodrinePhenylephrine
Labeled forn/aCough and cold, Allergies
Boxed warningYesNo
Pharmacy cost (NADAC)$0.111 per tablet 5 mg tablet$5.24 per mL 10% eye drop
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?